References
- Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44–84.
- Holvoet P. Oxidized LDL and coronary heart disease. Acta Cardiol. 2004;59:479–484.
- Braverman NE, Moser AB. Functions of plasmalogen lipids in health and disease. Biochim Biophys Acta. 2012;1822:1442–1452.
- Dorninger F, Brodde A, Braverman NE, et al. Homeostasis of phospholipids – the level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens. Biochim Biophys Acta. 2015;1851:117–128.
- Engelmann B. Plasmalogens: targets for oxidants and major lipophilic antioxidants. Biochem Soc Trans. 2004;32:147–150.
- Farooqui AA, Rapoport SI, Horrocks LA. Membrane phospholipid alterations in Alzheimer's disease: deficiency of ethanolamine plasmalogens. Neurochem Res. 1997;22:523–527.
- Khan M, Singh J, Singh I. Plasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatin. J Neurochem. 2008;106:1766–1779.
- Foglia TA, Nungesser E, Marmer WN. Oxidation of 1-O-(alk-1-enyl)-2,3-di-O-acylglycerols: models for plasmalogen oxidation. Lipids. 1988;23:430–434.
- Thukkani AK, McHowat J, Hsu FF, et al. Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions. Circulation. 2003;108:3128–3133.
- Weisser M, Vieth M, Stolte M, et al. Dramatic increase of alpha-hydroxyaldehydes derived from plasmalogens in the aged human brain. Chem Phys Lipids. 1997;90:135–142.
- Chirkin AA, Dotsenko EA, Kamyshnikova VS, et al. Physiological parameters of laboratory tests of the population of the Republic of Belarus: directory. Minsk: Adukatsiya i vykhavanne; 2010 [in Russian].
- Ruocco L, Del Corso L, Romanelli AM, et al. New hematological indices in the healthy elderly. Minerva Med. 2001;92:69–73.
- Berdyshev EV. Mass spectrometry of fatty aldehydes. Biochim Biophys Acta. 2011;1811:680–693.
- Dodge JT, Phillips GB. Composition of phospholipids and of phospholipid fatty acids and aldehydes in human red cells. J Lipid Res. 1967;8:667–675.
- Farquhar JW. Human erythrocyte phosphoglycerides. I. Quantification of plasmalogens, fatty acids and fatty aldehydes. Biochim Biophys Acta. 1962;60:80–89.
- Kates M. Techniques of lipidology: isolation, analysis and identification of lipids. Amsterdam (NY): North-Holland Pub. Co., American Elsevier; 1972.
- Watson AD, Leitinger N, Navab M, et al. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem. 1997;272:13597–13607.
- Glantz S. Primer of biostatistics. New York: McGraw-Hill; 1994.
- Graham RM, Frazier DP, Thompson JW, et al. A unique pathway of cardiac myocyte death caused by hypoxia-acidosis. J Exp Biol. 2004;207:3189–3200.
- Zubair AC. Clinical impact of blood storage lesions. Am J Hematol. 2010;85:117–122.
- Jackson MJ. Intracellular calcium, cell injury and relationships to free radicals and fatty acid metabolism. Proc Nutr Soc. 1990;49:77–81.
- Bogdanova A, Makhro A, Wang J, et al. Calcium in red blood cells—a perilous balance. Int J Mol Sci. 2013;14:9848–9872.
- Farooqui AA, Yang HC, Horrocks LA. Plasmalogens, phospholipases A2 and signal transduction. Brain Res Rev. 1995;21:152–161.
- Yang HC, Farooqui AA, Horrocks LA. Plasmalogen-selective phospholipase A2 and its role in signal transduction. J Lipid Mediat Cell Signal. 1996;14:9–13.
- Reed CF. Phospholipid exchange between plasma and erythrocytes in man and the dog. J Clin Invest. 1968;47:749–760.
- Gorgas K, Teigler A, Komljenovic D, et al. The ether lipid-deficient mouse: tracking down plasmalogen functions. Biochim Biophys Acta. 2006;1763:1511–1526.
- Magnusson CD, Haraldsson GG. Ether lipids. Chem Phys Lipids. 2011;164:315–340.
- Pike LJ, Han X, Chung KN, et al. Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis. Biochemistry. 2002;41:2075–2088.
- You S, Park B, Lee MS. Accelerated RBC senescence as a novel pathologic mechanism of blood stasis syndrome in traditional East Asian medicine. Am J Transl Res. 2015;7:422–429.
- Dougherty RM, Galli C, Ferro-Luzzi A, et al. Lipid and phospholipid fatty acid composition of plasma, red blood cells, and platelets and how they are affected by dietary lipids: a study of normal subjects from Italy, Finland, and the USA. Am J Clin Nutr. 1987;45:443–455.
- Gercken G, Tiling T, Brockmann U, et al. Fatty acid composition of phospholipids in erythrocytes of adults, normal newborn infants, and neonates with Rh erythroblastosis. Pediatr Res. 1972;6:487–494.
- Bosman GJ, Werre JM, Willekens FL, et al. Erythrocyte ageing in vivo and in vitro: structural aspects and implications for transfusion. Transfus Med. 2008;18:335–347.
- Edmondson JW, Li TK. The effects of ionophore A23187 on erythrocytes. Relationship of ATP and 2,3-diphosphoglycerate to calcium-binding capacity. Biochim Biophys Acta. 1976;443:106–113.
- Li H, Lykotrafitis G. Vesiculation of healthy and defective red blood cells. Phys Rev E Stat Nonlin Soft Matter Phys. 2015;92:012715.
- Rog T, Koivuniemi A. The biophysical properties of ethanolamine plasmalogens revealed by atomistic molecular dynamics simulations. Biochim Biophys Acta. 2016;1858:97–103.
- Salzer U, Zhu R, Luten M, et al. Vesicles generated during storage of red cells are rich in the lipid raft marker stomatin. Transfusion. 2008;48:451–462.
- Greenwalt TJ. The how and why of exocytic vesicles. Transfusion. 2006;46:143–152.